Neostigmine methylsulfate .5 mg/mL
Neostigmine methylsulfate · INJECTION · Amneal Pharmaceuticals LLC
Neostigmine methylsulfate is a injection containing neostigmine methylsulfate at .5 mg/mL, taken intravenous. Manufactured by Amneal Pharmaceuticals LLC.
Key Facts
- Brand Name
- Neostigmine methylsulfate
- Generic Name
- Neostigmine methylsulfate
- NDC Code (Product)
70121-1478- Manufacturer
- Amneal Pharmaceuticals LLC
- Strength
- .5 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA210051
- Marketing Start
- 06/20/2018
Recall History
US Compounding Inc
Labelling: Missing label.
KRS Global Biotechnology, Inc
Lack of Assurance of Sterility
Premier Pharmacy Labs Inc
Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.
Attix Pharmaceuticals
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
KRS Global Biotechnology, Inc
Lack of Assurance of Sterility
Cantrell Drug Company
Lack of Sterility Assurance.
Advanced Pharma Inc.
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Nephron Sterile Compounding Center LLC
Lack of Assurance of Sterility
Premier Pharmacy Labs Inc
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Nephron Sterile Compounding Center LLC
CGMP Deviations: Potential for cross contamination due to product carry over.
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Neostigmine methylsulfate used for?
Neostigmine methylsulfate contains Neostigmine methylsulfate. It is a injection taken intravenous. Consult your doctor for specific uses.
Is Neostigmine methylsulfate a controlled substance?
Neostigmine methylsulfate is not classified as a controlled substance by the DEA.
What is the generic name for Neostigmine methylsulfate?
The generic name for Neostigmine methylsulfate is Neostigmine methylsulfate. There are 11 other brand versions of Neostigmine methylsulfate.
What is the NDC code for Neostigmine methylsulfate .5 mg/mL?
The NDC (National Drug Code) for Neostigmine methylsulfate .5 mg/mL is 70121-1478, listed by Amneal Pharmaceuticals LLC.
Other Neostigmine methylsulfate Dosages
Other Neostigmine Brands
See all →- Neostigmine Methylsulfate1 mg/mL72572-462
- Neostigmine Methylsulfate1 mg/mL0641-6265
- NEOSTIGMINE METHYLSULFATE1 mg/mL55150-349
- NEOSTIGMINE METHYLSULFATE1 mg/mL71872-7143
- Neostigmine Methylsulfate1 mg/mL71872-7271
- NEOSTIGMINE METHYLSULFATE1 mg/mL71872-7322
- NEOSTIGMINE METHYLSULFATE.5 mg/mL0548-9601
- Neostigmine Methylsulfate1 mg/mL0641-6149
- Neostigmine Methylsulfate.5 mg/mL0641-6264
- NEOSTIGMINE METHYLSULFATE1 mg/mL14445-414
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)